Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands

Journal of Hepatology

Volumn 63, Issue 5, 2015, Pages 1156-1163

  Van Meer, Suzanne ^a   De Man, Robert A ^b   Coenraad, Minneke J ^c   Sprengers, Dave ^b   Van Nieuwkerk, Karin M J ^d   Klümpen, Heinz Josef ^e   Jansen, Peter L M ^e   Ijzermans, Jan N M ^b   Van Oijen, Martijn G H ^a   Siersema, Peter D ^a   Van Erpecum, Karel J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Hepatocellular carcinoma; Surveillance; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; SORAFENIB;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTICENTER STUDY; NETHERLANDS; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RISK FACTOR; SURVIVAL RATE; TUMOR GROWTH; TUMOR VOLUME; ULTRASOUND; UPPER ABDOMINAL PAIN; WEIGHT REDUCTION; CARCINOMA, HEPATOCELLULAR; FOLLOW UP; HEALTH SURVEY; LIVER NEOPLASMS; MIDDLE AGED; MORBIDITY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; TIME FACTOR; TRENDS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MORBIDITY; NEOPLASM STAGING; NETHERLANDS; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TIME FACTORS;

EID: 84945476326     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.06.012     Document Type: Article

References (46)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. C.D. Witjes, H.E. Karim-Kos, O. Visser, S.A. van den Akker, E. de Vries, J.N. Ijzermans, and et al. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival Eur J Gastroenterol Hepatol 24 2012 450 457
3. S. van Meer, K.J. van Erpecum, G.H. Schrier, C. Verhoef, J. Verheij, R.A. de Man, and et al. Diagnostics and treatment of hepatocellular carcinoma in the Netherlands in the period 2003-2011 Ned Tijdschr Geneeskd 158 2014 A7074
4. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
5. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
6. M. Omata, L.A. Lesmana, R. Tateishi, P.J. Chen, S.M. Lin, H. Yoshida, and et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma Hepatol Int 4 2010 439 474
7. F.A. Lederle, and C. Pocha Screening for liver cancer: the rush to judgment Ann Intern Med 156 2012 387 389
8. B.H. Zhang, B.H. Yang, and Z.Y. Tang Randomized controlled trial of screening for hepatocellular carcinoma J Cancer Res Clin Oncol 130 2004 417 422
9. R. Aghoram, P. Cai, and J.A. Dickinson Alpha-fetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B Cochrane Database Syst Rev 9 2012 CD002799
10. J.G. Chen, D.M. Parkin, Q.G. Chen, J.H. Lu, Q.J. Shen, B.C. Zhang, and et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China J Med Screen 10 2003 204 209
11. D. Kansagara, J. Papak, A.S. Pasha, M. O'Neil, M. Freeman, R. Relevo, and et al. Screening for hepatocellular carcinoma in chronic liver disease: a systematic review Ann Intern Med 161 2014 261 269
12. A.G. Singal, A. Pillai, and J. Tiro Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis PLoS Med 11 2014 e1001624
13. A. Singal, M.L. Volk, A. Waljee, R. Salgia, P. Higgins, M.A. Rogers, and et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis Aliment Pharmacol Ther 30 2009 37 47
14. A. Colli, M. Fraquelli, G. Casazza, S. Massironi, A. Colucci, D. Conte, and et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review Am J Gastroenterol 101 2006 513 523
15. V. Santi, F. Trevisani, A. Gramenzi, A. Grignaschi, F. Mirici-Cappa, P.P. Del, and et al. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival J Hepatol 53 2010 291 297
16. K.H. Han, D.Y. Kim, J.Y. Park, S.H. Ahn, J. Kim, S.U. Kim, and et al. Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study J Clin Gastroenterol 47 2013 538 544
17. J.H. Wang, K.C. Chang, K.M. Kee, P.F. Chen, Y.H. Yen, P.L. Tseng, and et al. Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community Am J Gastroenterol 108 2013 416 424
18. J.C. Trinchet, C. Chaffaut, V. Bourcier, F. Degos, J. Henrion, H. Fontaine, and et al. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities Hepatology 54 2011 1987 1997
19. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
20. M.M. Oken, R.H. Creech, D.C. Tormey, J. Horton, T.E. Davis, E.T. McFadden, and et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 1982 649 655
21. F. Turati, C. Galeone, M. Rota, C. Pelucchi, E. Negri, V. Bagnardi, and et al. Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies Ann Oncol 25 2014 1526 1535
22. R. Wiesner, E. Edwards, R. Freeman, A. Harper, R. Kim, P. Kamath, and et al. Model for end-stage liver disease (MELD) and allocation of donor livers Gastroenterology 124 2003 91 96
23. S.W. Duffy, I.D. Nagtegaal, M. Wallis, F.H. Cafferty, N. Houssami, J. Warwick, and et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival Am J Epidemiol 168 2008 98 104
24. D. Atkins, D. Ross, and M. Kelley Acting in the face of uncertainty Ann Intern Med 161 2014 300 301
25. H.B. El-Serag, J.R. Kramer, G.J. Chen, Z. Duan, P.A. Richardson, and J.A. Davila Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA Gut 60 2011 992 997
26. H. Tanaka, K. Nouso, H. Kobashi, Y. Kobayashi, S. Nakamura, Y. Miyake, and et al. Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival Liver Int 26 2006 543 551
27. M.J. Tong, H.E. Sun, C. Hsien, and D.S. Lu Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic Dig Dis Sci 55 2010 826 835
28. G.L. Wong, V.W. Wong, G.M. Tan, K.I. Ip, W.K. Lai, Y.W. Li, and et al. Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis Liver Int 28 2008 79 87
29. A. Cucchetti, F. Trevisani, A. Pecorelli, V. Erroi, F. Farinati, F. Ciccarese, and et al. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma J Hepatol 61 2014 333 341
30. M. Schwartz A biomathematical approach to clinical tumor growth Cancer 14 1961 1272 1294
31. A. Furlan, D. Marin, F. Agnello, M. Di Martino, V. Di Marco, R. Lagalla, and et al. Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (
32. A. Cucchetti, M. Vivarelli, F. Piscaglia, B. Nardo, R. Montalti, G.L. Grazi, and et al. Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis J Hepatol 43 2005 310 316
33. B. Taouli, J.S. Goh, Y. Lu, A. Qayyum, B.M. Yeh, R.B. Merriman, and et al. Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging J Comput Assist Tomogr 29 2005 425 429
34. K. Kubota, H. Ina, Y. Okada, and T. Irie Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography Dig Dis Sci 48 2003 581 586
35. T. Sato, R. Tateishi, H. Yoshida, T. Ohki, R. Masuzaki, J. Imamura, and et al. Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C Hepatol Int 3 2009 544 550
36. J.C. Sheu, J.L. Sung, D.S. Chen, P.M. Yang, M.Y. Lai, C.S. Lee, and et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications Gastroenterology 89 1985 259 266
37. H.J. Vriend, E.L. Op de Coul, T.J. van de Laar, A.T. Urbanus, F.R. van der Klis, and H.J. Boot Hepatitis C virus seroprevalence in the Netherlands Eur J Public Health 22 2012 819 821
38. G.G. Baaten, G.J. Sonder, N.H. Dukers, R.A. Coutinho, and J.A. Van den Hoek Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004 J Med Virol 79 2007 1802 1810
39. S.J. Hahne, H.E. De Melker, M. Kretzschmar, L. Mollema, F.R. van der Klis, M.A. Van Der Sande, and et al. Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007 Epidemiol Infect 140 2012 1469 1480
40. J.A. Davila, R.O. Morgan, P.A. Richardson, X.L. Du, K.A. McGlynn, and H.B. El-Serag Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States Hepatology 52 2010 132 141
41. A.G. Singal, M. Nehra, B. Adams-Huet, A.C. Yopp, J.A. Tiro, J.A. Marrero, and et al. Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol 108 2013 425 432
42. J.A. Davila, L. Henderson, J.R. Kramer, F. Kanwal, P.A. Richardson, Z. Duan, and et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States Ann Intern Med 154 2011 85 93
43. F. Trevisani, G. Magini, V. Santi, A.M. Morselli-Labate, M.C. Cantarini, M.A. Di Nolfo, and et al. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance Am J Gastroenterol 102 2007 1022 1031
44. Y.H. Kuo, S.N. Lu, C.L. Chen, Y.F. Cheng, C.Y. Lin, C.H. Hung, and et al. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis Eur J Cancer 46 2010 744 751
45. M.J. Tong, D. Chavalitdhamrong, D.S. Lu, S.S. Raman, A. Gomes, J.P. Duffy, and et al. Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA J Clin Gastroenterol 44 2010 e63 e70
46. S.J. Cho, J.H. Yoon, S.S. Hwang, and H.S. Lee Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol 22 2007 1226 1231